首页 > 最新文献

Paediatric Respiratory Reviews最新文献

英文 中文
Bubble CPAP in neonatal care: mechanisms, evidence, and pathways to optimization. 气泡CPAP在新生儿护理:机制,证据和途径优化。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-27 DOI: 10.1016/j.prrv.2025.12.004
Amanda Gross, Emily R Campbell, Lidiaine Oliveira, Guilherme Sant'Anna, Wissam Shalish

Bubble continuous positive airway pressure (CPAP) is a widely used non-invasive respiratory support strategy for neonates and is commonly employed in the management of preterm infants with respiratory distress. Bubble CPAP generates continuous distending pressure by submerging the distal expiratory limb in water, producing low-amplitude, high-frequency pressure oscillations as airflow escapes and bubbles into the water canister. These oscillations, which are transmitted back to the neonate, vary dynamically with airway and lung mechanics and may contribute to the physiological benefits observed with bubble CPAP. This review summarizes the historical context, physiological rationale, clinical evidence supporting bubble CPAP, and areas for future optimization.

气泡持续气道正压通气(Bubble continuous positive airway pressure, CPAP)是一种广泛应用于新生儿的无创呼吸支持策略,常用于早产儿呼吸窘迫的治疗。气泡CPAP通过将呼气远端肢体浸入水中产生持续的扩张压力,当气流逸出并形成气泡进入水罐时,产生低振幅的高频压力振荡。这些振荡随着气道和肺力学的变化而动态变化,并可能有助于气泡CPAP观察到的生理益处。本文综述了气泡CPAP的历史背景、生理原理、支持气泡CPAP的临床证据以及未来优化的领域。
{"title":"Bubble CPAP in neonatal care: mechanisms, evidence, and pathways to optimization.","authors":"Amanda Gross, Emily R Campbell, Lidiaine Oliveira, Guilherme Sant'Anna, Wissam Shalish","doi":"10.1016/j.prrv.2025.12.004","DOIUrl":"https://doi.org/10.1016/j.prrv.2025.12.004","url":null,"abstract":"<p><p>Bubble continuous positive airway pressure (CPAP) is a widely used non-invasive respiratory support strategy for neonates and is commonly employed in the management of preterm infants with respiratory distress. Bubble CPAP generates continuous distending pressure by submerging the distal expiratory limb in water, producing low-amplitude, high-frequency pressure oscillations as airflow escapes and bubbles into the water canister. These oscillations, which are transmitted back to the neonate, vary dynamically with airway and lung mechanics and may contribute to the physiological benefits observed with bubble CPAP. This review summarizes the historical context, physiological rationale, clinical evidence supporting bubble CPAP, and areas for future optimization.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for obstructive sleep apnoea in obese children: a systematic review and meta-analysis. 肥胖儿童阻塞性睡眠呼吸暂停的危险因素:系统回顾和荟萃分析。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-26 DOI: 10.1016/j.prrv.2025.12.003
Catharina Tao, Mary Fortune, Emma A Webb, Theofilos Polychronakis

Background: Obstructive sleep apnoea (OSA) is prevalent among children with obesity and is associated with long-term morbidity.

Methods: We conducted a systematic review and meta-analysis of risk factors for OSA among children (0-18) who are overweight/obese. Risk factors reviewed included overall adiposity, regional fat distribution, adenotonsillar hypertrophy, sex, ethnicity, and airway neuromuscular tone. PubMed and Embase were searched in July 2025. Random-effects models were applied.

Results: Forty-seven studies were included. Children with OSA had higher BMI z-scores (mean difference (MD) = 0.30), neck circumference (MD = 2.19 cm), and waist circumference (MD = 5.99 cm) compared to obese children without OSA. Adenotonsillar hypertrophy and male sex associated with higher OSA odds (adenoid odds ratio (OR) = 3.28, tonsil OR = 4.16, Male OR = 1.51). Studies also suggested airway neuromuscular tone and non-Caucasian ethnicity as risk factors, but further research is needed.

Conclusion: OSA in obese children is likely to be multifactorial. Assessment accounting for multiple factors may improve screening accuracy and guide targeted interventions in this high-risk population.

背景:阻塞性睡眠呼吸暂停(OSA)在肥胖儿童中普遍存在,并与长期发病率相关。方法:我们对超重/肥胖儿童(0-18岁)的OSA危险因素进行了系统回顾和荟萃分析。危险因素包括整体肥胖、区域脂肪分布、腺扁桃体肥大、性别、种族和气道神经肌肉张力。PubMed和Embase于2025年7月被检索。采用随机效应模型。结果:纳入47项研究。与无OSA的肥胖儿童相比,OSA患儿的BMI z-score(平均差值(MD) = 0.30)、颈围(MD = 2.19 cm)和腰围(MD = 5.99 cm)均较高。腺扁桃体肥大和男性与较高的OSA风险相关(腺样体风险比(OR) = 3.28,扁桃体风险比= 4.16,男性风险比= 1.51)。研究还表明气道神经肌肉张力和非白种人种族是危险因素,但需要进一步的研究。结论:肥胖儿童的阻塞性睡眠呼吸暂停可能是多因素的。考虑多种因素的评估可以提高筛查的准确性,并指导对这一高危人群进行有针对性的干预。
{"title":"Risk factors for obstructive sleep apnoea in obese children: a systematic review and meta-analysis.","authors":"Catharina Tao, Mary Fortune, Emma A Webb, Theofilos Polychronakis","doi":"10.1016/j.prrv.2025.12.003","DOIUrl":"https://doi.org/10.1016/j.prrv.2025.12.003","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnoea (OSA) is prevalent among children with obesity and is associated with long-term morbidity.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis of risk factors for OSA among children (0-18) who are overweight/obese. Risk factors reviewed included overall adiposity, regional fat distribution, adenotonsillar hypertrophy, sex, ethnicity, and airway neuromuscular tone. PubMed and Embase were searched in July 2025. Random-effects models were applied.</p><p><strong>Results: </strong>Forty-seven studies were included. Children with OSA had higher BMI z-scores (mean difference (MD) = 0.30), neck circumference (MD = 2.19 cm), and waist circumference (MD = 5.99 cm) compared to obese children without OSA. Adenotonsillar hypertrophy and male sex associated with higher OSA odds (adenoid odds ratio (OR) = 3.28, tonsil OR = 4.16, Male OR = 1.51). Studies also suggested airway neuromuscular tone and non-Caucasian ethnicity as risk factors, but further research is needed.</p><p><strong>Conclusion: </strong>OSA in obese children is likely to be multifactorial. Assessment accounting for multiple factors may improve screening accuracy and guide targeted interventions in this high-risk population.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145944648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung trajectories into adulthood of preterm born survivors and the influence of sex. 早产幸存者进入成年期的肺部轨迹及性别的影响。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-24 DOI: 10.1016/j.prrv.2025.12.001
Dinh Son Bui, Cassidy Du Berry, Nur Sabrina Idrose, Jeanie L Y Cheong, Shyamali Dharmage

Preterm birth is increasingly recognised as a major determinant of lifelong respiratory health. Longitudinal studies consistently demonstrate that individuals born preterm have persistently worse lung function from childhood to adulthood compared with their term born peers. These adverse effects vary across gestational categories including extremely preterm, very preterm and moderate-late preterm birth, and are further exacerbated by bronchopulmonary dysplasia (BPD). Pooled analyses show that children or adults born preterm without BPD had 7.2% [95 confidence interval (CI): 5.6-8.7%] lower percent predicted FEV1 than term-born individuals. The %FEV1 deficit was greater in those with BPD: 18.9% [16.7-21.1%] lower for the BPD36 group when compared with the term born group. Lung function deficits in pre-term born survivors persist into adult life. Preterm birth is also associated with increased risk of COPD in later life. There is evidence that male sex confers additional vulnerability in pre-term survivors, with recent literature showing poorer lung function in males compared with females. Understanding these relationships is central to developing future phenotyping frameworks, enabling early identification of those at greatest risk, and informing surveillance strategies aimed at preserving lung function and preventing early onset of chronic obstructive pulmonary disease.

早产越来越被认为是影响终生呼吸系统健康的一个主要因素。纵向研究一致表明,与足月出生的同龄人相比,早产儿从童年到成年的肺功能一直较差。这些不良反应因妊娠类别而异,包括极早产儿、极早产儿和中晚期早产儿,并因支气管肺发育不良(BPD)而进一步加剧。汇总分析显示,与足月出生的个体相比,无BPD的早产儿或成人的FEV1预测值低7.2%[95可信区间(CI): 5.6-8.7%]。与足月出生组相比,BPD36组FEV1的%缺陷更大:比足月出生组低18.9%[16.7-21.1%]。早产儿幸存者的肺功能缺陷会持续到成年。早产也与晚年患慢性阻塞性肺病的风险增加有关。有证据表明,男性会给早产幸存者带来额外的脆弱性,最近的文献显示,男性的肺功能比女性差。了解这些关系对于制定未来的表型框架至关重要,能够早期识别风险最大的人群,并为旨在保护肺功能和预防慢性阻塞性肺疾病早期发病的监测策略提供信息。
{"title":"Lung trajectories into adulthood of preterm born survivors and the influence of sex.","authors":"Dinh Son Bui, Cassidy Du Berry, Nur Sabrina Idrose, Jeanie L Y Cheong, Shyamali Dharmage","doi":"10.1016/j.prrv.2025.12.001","DOIUrl":"https://doi.org/10.1016/j.prrv.2025.12.001","url":null,"abstract":"<p><p>Preterm birth is increasingly recognised as a major determinant of lifelong respiratory health. Longitudinal studies consistently demonstrate that individuals born preterm have persistently worse lung function from childhood to adulthood compared with their term born peers. These adverse effects vary across gestational categories including extremely preterm, very preterm and moderate-late preterm birth, and are further exacerbated by bronchopulmonary dysplasia (BPD). Pooled analyses show that children or adults born preterm without BPD had 7.2% [95 confidence interval (CI): 5.6-8.7%] lower percent predicted FEV<sub>1</sub> than term-born individuals. The %FEV<sub>1</sub> deficit was greater in those with BPD: 18.9% [16.7-21.1%] lower for the BPD<sub>36</sub> group when compared with the term born group. Lung function deficits in pre-term born survivors persist into adult life. Preterm birth is also associated with increased risk of COPD in later life. There is evidence that male sex confers additional vulnerability in pre-term survivors, with recent literature showing poorer lung function in males compared with females. Understanding these relationships is central to developing future phenotyping frameworks, enabling early identification of those at greatest risk, and informing surveillance strategies aimed at preserving lung function and preventing early onset of chronic obstructive pulmonary disease.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145952176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Home intravenous antibiotics for cystic fibrosis - setting up a hospital @home service. 家庭静脉注射抗生素治疗囊性纤维化——建立医院@家庭服务。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-18 DOI: 10.1016/j.prrv.2025.12.002
Nicola Collins, Caroline Devon, Siân Bentley, Emma Dixon, Delyth Jones, Suzie Kenny, Sukeshi Makhecha, Sarah Moledina, Nicola Murray, Michèle Puckey, Chloe Worger, Ian M Balfour-Lynn

This paper reviews the use of home intravenous antibiotics (IVABs) in children with cystic fibrosis (CF). We outline a program we developed during the COVID-19 pandemic for enhancing the experience for children and families by involving full multidisciplinary follow up via video for the duration of the antibiotic course. We did find though, that the majority of families were unsuitable for home IVABs. We hope that this information will be useful for other CF units considering setting up a hospital at home service.

本文综述了家庭静脉注射抗生素(IVABs)在儿童囊性纤维化(CF)中的应用。我们概述了我们在2019冠状病毒病大流行期间制定的一项计划,该计划通过在抗生素疗程期间通过视频进行全面的多学科随访,以增强儿童和家庭的体验。但我们确实发现,大多数家庭不适合进行家庭ivab。我们希望这一信息将对其他CF单位考虑建立家庭医院服务有所帮助。
{"title":"Home intravenous antibiotics for cystic fibrosis - setting up a hospital @home service.","authors":"Nicola Collins, Caroline Devon, Siân Bentley, Emma Dixon, Delyth Jones, Suzie Kenny, Sukeshi Makhecha, Sarah Moledina, Nicola Murray, Michèle Puckey, Chloe Worger, Ian M Balfour-Lynn","doi":"10.1016/j.prrv.2025.12.002","DOIUrl":"https://doi.org/10.1016/j.prrv.2025.12.002","url":null,"abstract":"<p><p>This paper reviews the use of home intravenous antibiotics (IVABs) in children with cystic fibrosis (CF). We outline a program we developed during the COVID-19 pandemic for enhancing the experience for children and families by involving full multidisciplinary follow up via video for the duration of the antibiotic course. We did find though, that the majority of families were unsuitable for home IVABs. We hope that this information will be useful for other CF units considering setting up a hospital at home service.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145864403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cleft palate surgery and speech outcomes in children with Robin sequence 罗宾序列患儿腭裂手术与语言预后。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-02-07 DOI: 10.1016/j.prrv.2025.02.001
Curtis Budden , Loredana Cuglietta , Amir Sadri
Robin sequence (RS) is diagnosed by the clinical triad of micrognathia, glossoptosis, and airway obstruction. The reported occurrence is variable and noted in 1:8,500 to 1:20,000 live births. Although advances in perinatal imaging, neonatal resuscitation, non-invasive respiratory support and surgical techniques can mitigate against adverse outcomes, there remains much debate as to the best treatment for children born with RS. This review will outline surgical treatment of cleft palate and speech outcomes for children with RS.
罗宾序列(Robin sequence, RS)是由小颌、舌下垂和气道阻塞的临床三联征来诊断的。报告的发生率是可变的,以1:8 500到1:20 000的活产率为例。尽管围产期成像、新生儿复苏、无创呼吸支持和手术技术的进步可以减轻不良后果,但对于先天性腭裂儿童的最佳治疗方法仍存在许多争议。本文将概述腭裂儿童的手术治疗和言语预后。
{"title":"Cleft palate surgery and speech outcomes in children with Robin sequence","authors":"Curtis Budden ,&nbsp;Loredana Cuglietta ,&nbsp;Amir Sadri","doi":"10.1016/j.prrv.2025.02.001","DOIUrl":"10.1016/j.prrv.2025.02.001","url":null,"abstract":"<div><div><span>Robin sequence (RS) is diagnosed by the clinical triad of micrognathia<span>, glossoptosis, and airway obstruction. The reported occurrence is variable and noted in 1:8,500 to 1:20,000 live births. Although advances in perinatal imaging, </span></span>neonatal resuscitation<span><span>, non-invasive respiratory support and surgical techniques can mitigate against </span>adverse outcomes, there remains much debate as to the best treatment for children born with RS. This review will outline surgical treatment of cleft palate and speech outcomes for children with RS.</span></div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 55-60"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143524007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Overlooked and underdone: Treatment of ear and nasal problems in children 社论:忽视和不充分:儿童耳鼻病的治疗。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-07-25 DOI: 10.1016/j.prrv.2025.07.001
Dominic A. Fitzgerald , Hannah North
{"title":"Editorial: Overlooked and underdone: Treatment of ear and nasal problems in children","authors":"Dominic A. Fitzgerald ,&nbsp;Hannah North","doi":"10.1016/j.prrv.2025.07.001","DOIUrl":"10.1016/j.prrv.2025.07.001","url":null,"abstract":"","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 1-2"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144963859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Measles is misery: A brief update for paediatricians 麻疹是痛苦:儿科医生的简要更新。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-10-26 DOI: 10.1016/j.prrv.2025.10.003
Nichkamol Lertamornkitti , Philip N. Britton
Measles is an important vaccine-preventable disease that has re-emerged in recent years. Since the COVID-19 pandemic, interruptions to routine immunisation programs and declining vaccine coverage have altered the incidence and patterns of respiratory virus infections. Global outbreaks have intensified, and vaccine hesitancy is recognised as major health threat. Revisiting the clinical presentation of measles is crucial for early diagnosis and to reduce transmission of this highly contagious infection. As serious respiratory and neurological complications can follow natural infection and no specific antiviral therapy is available, vaccination remains the most effective strategy for prevention and control.
麻疹是近年来重新出现的一种重要的疫苗可预防疾病。自2019冠状病毒病大流行以来,常规免疫规划中断和疫苗覆盖率下降改变了呼吸道病毒感染的发病率和模式。全球疫情加剧,疫苗犹豫被认为是主要的健康威胁。重新审视麻疹的临床表现对于早期诊断和减少这种高度传染性感染的传播至关重要。由于自然感染后可能出现严重的呼吸道和神经系统并发症,而且没有特定的抗病毒治疗,因此疫苗接种仍然是最有效的预防和控制策略。
{"title":"Measles is misery: A brief update for paediatricians","authors":"Nichkamol Lertamornkitti ,&nbsp;Philip N. Britton","doi":"10.1016/j.prrv.2025.10.003","DOIUrl":"10.1016/j.prrv.2025.10.003","url":null,"abstract":"<div><div>Measles is an important vaccine-preventable disease that has re-emerged in recent years. Since the COVID-19 pandemic, interruptions to routine immunisation programs and declining vaccine coverage have altered the incidence and patterns of respiratory virus infections. Global outbreaks have intensified, and vaccine hesitancy is recognised as major health threat. Revisiting the clinical presentation of measles is crucial for early diagnosis and to reduce transmission of this highly contagious infection. As serious respiratory and neurological complications can follow natural infection and no specific antiviral therapy is available, vaccination remains the most effective strategy for prevention and control.</div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 24-28"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145513396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of intratracheal budesonide plus surfactant vs. Surfactant alone on bronchopulmonary dysplasia in preterm Infants: A meta-analysis of randomized controlled trials 气管内布地奈德加表面活性剂与单独表面活性剂治疗早产儿支气管肺发育不良的疗效:随机对照试验的荟萃分析。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-03-03 DOI: 10.1016/j.prrv.2025.02.003
Aluisio D’lucas Alves Gomes , Elísio Bulhões , Danielle Costa do Amaral , Luis Felipe Matos de Sousa , Ely Cavalcante Lima Júnior , José Airton Alves Ferreira , Hilderlania Alves de Oliveira , Maria LR Defante , Jafar Aljazeeri

Background

Bronchopulmonary dysplasia (BPD) is a chronic pulmonary disease commonly affecting preterm infants. The potential benefits of combining budesonide with surfactant for preterms with early BPD remain uncertain and warrant further exploration.

Objective

We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of intratracheal budesonide plus surfactant compared with surfactant alone in preterm infants.

Methods

We searched PubMed, Embase and Cochrane Central databases from inception to November 2024. We conducted a meta-analysis following the PRISMA guidelines. We calculated the risk ratios (RRs) of endpoints of interest with 95% confidence intervals using a random effects model. R software (version 4.3.2) was used for statistical analyses. Heterogeneity was assessed with I2 statistics.

Results

Eight RCTs including 2029 preterm infants were included. Compared with surfactant alone, a combined intratracheal budesonide plus surfactant significantly reduced the risk of bronchopulmonary dysplasia (RR: 0.70; 95 % CI: 0.54–0.91; p = 0.007; I2 = 71.4 %), mortality (RR: 0.81; 95 % CI: 0.66–0.98; p = 0.029; I2 = 14.6 %), pulmonary hemorrhage (RR: 0.58; 95 % CI: 0.37–0.90; p = 0.015; I2 = 0 %) and patent ductus arteriosus (RR: 0.84; 95 % CI: 0.75–0.94; p = 0.004; I2 = 0 %).

Conclusion

This meta-analysis found that intratracheal budesonide plus surfactant reduces the risk of bronchopulmonary dysplasia, mortality, pulmonary hemorrhage and patent ductus arteriosus compared with surfactant alone. Given its potential to reduce pulmonary complications associated with prematurity, clinicians may consider this combination therapy.
背景:支气管肺发育不良(BPD)是一种常见于早产儿的慢性肺部疾病。布地奈德联合表面活性剂治疗早期BPD的潜在益处尚不确定,值得进一步探索。目的:我们对随机对照试验(RCTs)进行系统回顾和荟萃分析,评价气管内布地奈德联合表面活性剂与单独表面活性剂治疗早产儿的疗效。方法:检索PubMed、Embase和Cochrane Central数据库,检索时间为成立至2024年11月。我们按照PRISMA指南进行了荟萃分析。我们使用随机效应模型以95%的置信区间计算感兴趣终点的风险比(rr)。采用R软件(4.3.2版)进行统计分析。采用I2统计量评估异质性。结果:共纳入8项随机对照试验,共纳入早产儿2029例。与单用表面活性剂相比,气管内布地奈德联合表面活性剂可显著降低支气管肺发育不良的风险(RR: 0.70;95 % ci: 0.54-0.91;p = 0.007;I2 = 71.4 %),死亡率(RR: 0.81;95 % ci: 0.66-0.98;p = 0.029;I2 = 14.6 %),肺出血(RR: 0.58;95 % ci: 0.37-0.90;p = 0.015;I2 = 0 %)和动脉导管未闭(RR: 0.84;95 % ci: 0.75-0.94;p = 0.004;I2 = 0 %)。结论:本荟萃分析发现,与单用表面活性剂相比,气管内布地奈德联合表面活性剂可降低支气管肺发育不良、死亡率、肺出血和动脉导管未闭的风险。鉴于其减少早产相关肺部并发症的潜力,临床医生可能会考虑这种联合治疗。
{"title":"Efficacy of intratracheal budesonide plus surfactant vs. Surfactant alone on bronchopulmonary dysplasia in preterm Infants: A meta-analysis of randomized controlled trials","authors":"Aluisio D’lucas Alves Gomes ,&nbsp;Elísio Bulhões ,&nbsp;Danielle Costa do Amaral ,&nbsp;Luis Felipe Matos de Sousa ,&nbsp;Ely Cavalcante Lima Júnior ,&nbsp;José Airton Alves Ferreira ,&nbsp;Hilderlania Alves de Oliveira ,&nbsp;Maria LR Defante ,&nbsp;Jafar Aljazeeri","doi":"10.1016/j.prrv.2025.02.003","DOIUrl":"10.1016/j.prrv.2025.02.003","url":null,"abstract":"<div><h3>Background</h3><div><span><span>Bronchopulmonary dysplasia (BPD) is a </span>chronic pulmonary disease commonly affecting preterm infants. The potential benefits of combining </span>budesonide with surfactant for preterms with early BPD remain uncertain and warrant further exploration.</div></div><div><h3>Objective</h3><div><span>We conducted a systematic review and </span><em>meta</em><span>-analysis of randomized controlled trials<span> (RCTs) to evaluate the efficacy of intratracheal budesonide plus surfactant compared with surfactant alone in preterm infants.</span></span></div></div><div><h3>Methods</h3><div>We searched PubMed, Embase and Cochrane Central databases from inception to November 2024. We conducted a <em>meta</em>-analysis following the PRISMA guidelines. We calculated the risk ratios (RRs) of endpoints of interest with 95% confidence intervals using a random effects model. R software (version 4.3.2) was used for statistical analyses. Heterogeneity was assessed with I<sup>2</sup> statistics.</div></div><div><h3>Results</h3><div>Eight RCTs including 2029 preterm infants were included. Compared with surfactant alone, a combined intratracheal budesonide plus surfactant significantly reduced the risk of bronchopulmonary dysplasia (RR: 0.70; 95 % CI: 0.54–0.91; p = 0.007; I<sup>2</sup> = 71.4 %), mortality (RR: 0.81; 95 % CI: 0.66–0.98; p = 0.029; I<sup>2</sup><span> = 14.6 %), pulmonary hemorrhage (RR: 0.58; 95 % CI: 0.37–0.90; p = 0.015; I</span><sup>2</sup><span> = 0 %) and patent ductus arteriosus (RR: 0.84; 95 % CI: 0.75–0.94; p = 0.004; I</span><sup>2</sup> = 0 %).</div></div><div><h3>Conclusion</h3><div>This <em>meta</em><span>-analysis found that intratracheal budesonide plus surfactant reduces the risk of bronchopulmonary dysplasia, mortality, pulmonary hemorrhage<span> and patent ductus arteriosus compared with surfactant alone. Given its potential to reduce pulmonary complications associated with prematurity, clinicians may consider this combination therapy.</span></span></div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 68-74"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glue ear: an ongoing global program – closing the audiology gap among First Nations children 胶耳:一个正在进行的全球项目-缩小第一民族儿童的听力差距。
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2025-05-04 DOI: 10.1016/j.prrv.2025.04.011
Isabella Ludbrook , Georgia Tongs Wiradjuri , Kelvin Kong Worimi , Hasantha Gunasekera
Most children globally (~80%) are affected by Otitis Media with Effusion (OME; ‘serous otitis media’ or ‘glue ear’) by four years of age. Most episodes resolve in a timely manner are brief and uncomplicated. Chronic, recurrent and complicated OME has been linked to social disadvantage, with poorer educational and employment outcomes and increased criminal justice system contact. Specific populations are particularly at risk, even in High Income Countries, including children with craniofacial abnormalities, immunocompromise and First Nations children in colonised regions (e.g., Australia, New Zealand, and the Arctic Circle).
OME is a significant cause of childhood morbidity, particularly during infancy. Mortality should not occur in High-Income-Countries. However, in Low-Middle-Income Countries, lack of access to health programs can lead to devastating, preventable complications, including death from meningitis, brain abscesses, and sepsis. This emphasises the importance of equitable access to medical resources globally, a universal and ongoing problem for First Nations people.
Upper respiratory tract infections (including OME), are the most common reason for children to present to healthcare services, be prescribed antibiotics, and undergo surgery. Although OME is often managed by with antibiotics, guidelines recommend observation for uncomplicated cases, given potential harms for the child (e.g., rash and diarrhoea), and for healthcare (e.g., cost and antibiotic resistance). OME is also the most common reason for hearing impairment among children, and peaks at the time that auditory processing neural pathways, the foundations of cognitive development, are being laid down. Causative effect between OME and impaired cognitive function is hard to prove because of the challenges of designing and analysing rigorous observational studies to emulate clinical trials.
Recurrent OME cannot be left untreated due to the potential for its effect on hearing loss and both severe physical harm and significant long-term social consequences. Clinicians should be aware that children’s behavioural and developmental outcomes and balance disturbance may indicate middle ear disease or its sequelae and remain vigilant. Children’s ears should be checked and findings documented at every healthcare visit to ensure close surveillance for this insidious condition, particularly for those most at-risk.
全球大多数儿童(约80%)患有积液性中耳炎(OME;“严重中耳炎”或“胶耳”)。大多数情节都很简短,并不复杂。慢性、复发性和复杂的OME与社会劣势有关,教育和就业结果较差,刑事司法系统接触增加。即使在高收入国家,特定人群也特别面临风险,包括颅面异常、免疫功能低下的儿童和殖民地区(如澳大利亚、新西兰和北极圈)的原住民儿童。OME是儿童发病的重要原因,特别是在婴儿期。高收入国家不应出现死亡率。然而,在中低收入国家,缺乏获得卫生规划的机会可能导致毁灭性的、可预防的并发症,包括脑膜炎、脑脓肿和败血症导致的死亡。这强调了在全球公平获得医疗资源的重要性,这是第一民族普遍和持续存在的问题。上呼吸道感染(包括OME)是儿童就诊、服用抗生素和接受手术的最常见原因。尽管OME通常使用抗生素治疗,但鉴于对儿童的潜在危害(如皮疹和腹泻)和卫生保健(如费用和抗生素耐药性),指南建议对无并发症病例进行观察。OME也是儿童听力受损的最常见原因,在认知发展的基础听觉处理神经通路形成时达到高峰。由于设计和分析严格的观察性研究以模拟临床试验的挑战,OME和认知功能受损之间的因果关系很难证明。由于可能造成严重的身体伤害和严重的长期社会后果,复发性OME不能置之不理。临床医生应该意识到,儿童的行为和发育结果以及平衡障碍可能表明中耳疾病或其后遗症,并保持警惕。应在每次就诊时检查儿童的耳朵,并记录检查结果,以确保对这种潜在疾病进行密切监测,特别是对那些最危险的儿童。
{"title":"Glue ear: an ongoing global program – closing the audiology gap among First Nations children","authors":"Isabella Ludbrook ,&nbsp;Georgia Tongs Wiradjuri ,&nbsp;Kelvin Kong Worimi ,&nbsp;Hasantha Gunasekera","doi":"10.1016/j.prrv.2025.04.011","DOIUrl":"10.1016/j.prrv.2025.04.011","url":null,"abstract":"<div><div>Most children globally (~80%) are affected by Otitis Media with Effusion (OME; ‘serous otitis media’ or ‘glue ear’) by four years of age. Most episodes resolve in a timely manner are brief and uncomplicated. Chronic, recurrent and complicated OME has been linked to social disadvantage, with poorer educational and employment outcomes and increased criminal justice system contact. Specific populations are particularly at risk, even in High Income Countries, including children with craniofacial abnormalities, immunocompromise and First Nations children in colonised regions (e.g., Australia, New Zealand, and the Arctic Circle).</div><div>OME is a significant cause of childhood morbidity, particularly during infancy. Mortality should not occur in High-Income-Countries. However, in Low-Middle-Income Countries, lack of access to health programs can lead to devastating, preventable complications, including death from meningitis, brain abscesses, and sepsis. This emphasises the importance of equitable access to medical resources globally, a universal and ongoing problem for First Nations people.</div><div>Upper respiratory tract infections (including OME), are the most common reason for children to present to healthcare services, be prescribed antibiotics, and undergo surgery. Although OME is often managed by with antibiotics, guidelines recommend observation for uncomplicated cases, given potential harms for the child (e.g., rash and diarrhoea), and for healthcare (e.g., cost and antibiotic resistance). OME is also the most common reason for hearing impairment among children, and peaks at the time that auditory processing neural pathways, the foundations of cognitive development, are being laid down. Causative effect between OME and impaired cognitive function is hard to prove because of the challenges of designing and analysing rigorous observational studies to emulate clinical trials.</div><div>Recurrent OME cannot be left untreated due to the potential for its effect on hearing loss and both severe physical harm and significant long-term social consequences. Clinicians should be aware that children’s behavioural and developmental outcomes and balance disturbance may indicate middle ear disease or its sequelae and remain vigilant. Children’s ears should be checked and findings documented at every healthcare visit to ensure close surveillance for this insidious condition, particularly for those most at-risk.</div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 15-23"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144187554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New paradigms in acute viral bronchiolitis: Is it time to change our approach? 急性病毒性支气管炎的新模式:是时候改变我们的方法了吗?
IF 4 3区 医学 Q1 PEDIATRICS Pub Date : 2025-12-01 Epub Date: 2024-11-01 DOI: 10.1016/j.prrv.2024.10.004
Jose A. Castro-Rodriguez , Patricio Astudillo , Sandeep Puranik , Mark A. Brown , Adnan Custovic , Erick Forno
Viral bronchiolitis is the most common pediatric acute respiratory infection leading to hospitalization, and it causes a significant healthcare burden worldwide. Current guidelines recommend supportive management after many clinical trials on specific therapies failed to demonstrate benefits. However, several studies in the past decade have revealed that bronchiolitis may not be a homogeneous disease, but instead may constitute an umbrella comprised of different “endotypes” and “phenotypes” based on patient characteristics, etiology, pathophysiological mechanisms, and clinical presentation. In this extensive review, we summarize the current evidence that several different types of bronchiolitis (“bronchiolitides”) coexist, with different short- and long-term consequences on respiratory health and the risk of asthma development. Disease pathobiology, immune response, and clinical characteristics may differ between the two most prevalent viral agents, respiratory syncytial virus and rhinovirus. Recent randomized trials have shown that some subgroups of children may benefit from the use of systemic corticosteroids and/or bronchodilators. These findings also suggest that some children may benefit from individualized therapeutical approaches for viral bronchiolitis rather than following broad recommendations for treating all patients uniformly using only supportive management.
病毒性支气管炎是导致住院治疗的最常见的儿科急性呼吸道感染,在全球范围内造成了巨大的医疗负担。在许多关于特定疗法的临床试验未能证明其疗效后,现行指南建议采取支持性治疗。然而,近十年来的多项研究表明,支气管炎可能并不是一种单一的疾病,而是由基于患者特征、病因、病理生理机制和临床表现的不同 "内型 "和 "表型 "组成的伞状疾病。在这篇内容广泛的综述中,我们总结了目前的证据,即几种不同类型的支气管炎("支气管炎")并存,对呼吸系统健康和哮喘发病风险造成不同的短期和长期后果。呼吸道合胞病毒和鼻病毒这两种最常见的病毒病原体的疾病病理生物学、免疫反应和临床特征可能有所不同。最近的随机试验表明,某些亚组儿童可能从使用全身性皮质类固醇激素和/或支气管扩张剂中获益。这些研究结果还表明,一些儿童可能会从针对病毒性支气管炎的个体化治疗方法中获益,而不是遵循广泛的建议,对所有患者统一采用支持性治疗方法。
{"title":"New paradigms in acute viral bronchiolitis: Is it time to change our approach?","authors":"Jose A. Castro-Rodriguez ,&nbsp;Patricio Astudillo ,&nbsp;Sandeep Puranik ,&nbsp;Mark A. Brown ,&nbsp;Adnan Custovic ,&nbsp;Erick Forno","doi":"10.1016/j.prrv.2024.10.004","DOIUrl":"10.1016/j.prrv.2024.10.004","url":null,"abstract":"<div><div><span><span><span><span>Viral bronchiolitis is the most common pediatric </span>acute respiratory infection leading to hospitalization, and it causes a significant healthcare burden worldwide. Current guidelines recommend supportive management after many </span>clinical trials on specific therapies failed to demonstrate benefits. However, several studies in the past decade have revealed that bronchiolitis may not be a homogeneous disease, but instead may constitute an umbrella comprised of different “endotypes” and “phenotypes” based on </span>patient characteristics<span>, etiology, pathophysiological mechanisms, and clinical presentation. In this extensive review, we summarize the current evidence that several different types of bronchiolitis (“bronchiolitides”) coexist, with different short- and long-term consequences on respiratory health and the risk of asthma development. Disease pathobiology, immune response, and clinical characteristics may differ between the two most prevalent viral agents, respiratory syncytial virus and </span></span>rhinovirus<span><span>. Recent randomized trials have shown that some subgroups of children may benefit from the use of systemic corticosteroids and/or </span>bronchodilators. These findings also suggest that some children may benefit from individualized therapeutical approaches for viral bronchiolitis rather than following broad recommendations for treating all patients uniformly using only supportive management.</span></div></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"56 ","pages":"Pages 29-36"},"PeriodicalIF":4.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142730969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Paediatric Respiratory Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1